Ontogeny of phencyclidine and apomorphine-induced startle gating deficits in rats

Pharmacology Biochemistry and Behavior

Volumn 65, Issue 3, 2000, Pages 449-457

  Martinez, Zoe A ^a   Halim, Nader D ^b   Oostwegel, Jeff L ^c   Geyer, Mark A ^b   Swerdlow, Neal R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Apomorphine; Development; Neurotoxicity; Phencyclidine; Prepulse inhibition; Schizophrenia; Sensorimotor; Startle

Indexed keywords

APOMORPHINE; PHENCYCLIDINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR MODIFICATION; BRAIN; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HISTOLOGY; LIMBIC SYSTEM; MALE; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; ONTOGENY; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SENSORIMOTOR FUNCTION; STARTLE REFLEX;

AGE FACTORS; ANIMALS; APOMORPHINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MALE; PHENCYCLIDINE; RATS; RATS, SPRAGUE-DAWLEY; SCHIZOPHRENIA; STARTLE REACTION;

EID: 0033981884     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(99)00217-8     Document Type: Article

References (44)

1. Bolino F., Di Michele V., Di Cicco L., Manna V., Daneluzzo E., Casacchia M. Sensorimotor gating and habituation evoked by electro-cutaneous stimulation in schizophrenia. Biol. Psychiatry. 36:1994;670-679.
2. Braff D., Grillon C., Geyer M. Gating and habituation of the startle reflex in schizophrenic patients. Arch. Gen. Psychiatry. 49:1992;206-215.
3. Braff D., Stone C., Callaway E., Geyer M.A., Glick I.D., Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology. 15:1978;339-343.
4. Cadenhead K.S., Geyer M.A., Braff D.L. Impaired startle prepulse inhibition and habituation in schizotypal personality disordered patients. Am. J. Psychiatry. 150:1993;1862-1867.
5. Cadenhead K.S., Geyer M.A., Swerdlow N.R., Shafer K., Diaz M., Clementz B.A., Braff D.L. Sensorimotor gating deficits in schizophrenic patients and their relatives. Biol. Psychiatr. Abstr. 43:1998;10S.
6. Cronin M.M., Bonsfield J.D., Hewett E.B., Boulton T.B. Ketamine anaesthesia for radiotherapy in small children. Anaesthesia. 27:1972;135-142.
7. Ellenbroek B.A., Geyer M.A., Cools A.R. The behavior of APO-SUS rats in animal models with construct validity for schizophrenia. J. Neurosci. 15:1995;7604-7611.
8. Ellison G. Neuronal degeneration following both competitive and non-competitive NMDA antagonists. Neuroreport. 5:1994;2688-2692.
9. Ellison G., Switzer R.C. Dissimilar patterns of degeneration in brain following four different addictive stimulants. Neuroreport. 5:1997;17-20.
10. Elliot E., Hanid T.K., Arthur L.J.H., Kaj B. Ketamine anaesthesia for medical procedures in children. Arch. Dis. Child. 51:1976;56-59.
11. Farber N.B., Wozniak D.F., Price M.T., Labruyere J., Huss J., St. Peter H., Olney J.W. Age-specific neurotoxicity in the rat associated with NMDA receptor blockade. Potential relevance to schizophrenia? Soc. Biol. Psychiatry. 38:1995;788-796.
12. Fix A.S., Horn J.W., Wightman K.A., Johnson C.A., Long G.C., Storts R.W., Farber N., Wozniak D.F., Olney J.W. Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (Dizocilpine Maleate). A light and electron microscopic evaluation of the rat retrosplenial cortex Exp. Neurol. 123:1993;204-215.
13. Geyer M.A., Swerdlow N.R. Measurement of startle response, prepulse inhibition, and habituation. Crawley J.N., Skolnick P. Current protocols in neuroscience. 1998;8 John Wiley & Sons, New York. 7.1-8.7.15.
14. Grillon C., Ameli R., Charney D.S., Krystal J., Braff D. Startle gating deficits occur across prepulse intensities in schizophrenic patients. Biol. Psychiatry. 32:1992;939-943.
15. Kinney G.G., Wilkonson L.O., Saywell K.L., Tircklebank M.D. Rat strain differences in ability to disrupt sensorimotor gating are limited to the dopaminergic system, specific to prepulse inhibition, and unrelated to changes in startle amplitude or nucleus accumbens dopamine receptor sensitivity. J. Neurosci. 19:1999;5644-5653.
16. Koch M., Schnitzler H.U. The acoustic startle response in rats - Circuits mediating evocation, inhibition and potentiation. Behav. Brain Res. 89:1997;35-49.
17. Kolb B., Nonneman A.J. Functional development of prefrontal cortex in rats continues into adolescence. Science. 193:1976;335-336.
18. Kolb B., Nonneman A.J. Sparing of function in rats with early prefrontal cortex lesions. Brain Res. 151:1978;135-148.
19. Krestow M. The effect of post-anaesthetic dreaming on patient acceptance of ketamine anaesthesia. A comparison with thiopentone-nitrous oxide anaesthesia Can. Anaesth. Soc. J. 21:1974;385-389.
20. Lipska B.K., Weinberger D.R. Delayed effects of neonatal hippocampal damage on haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat. Dev. Brain Res. 75:1993;213-222.
21. Lipska B.K., Swerdlow N.R., Geyer M.A., Jaskiw G.E., Braff D.L., Weinberger D.R. Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology (Berlin). 122:1995;35-43.
22. Mansbach R.S., Geyer M.A. Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat. Neuropsychopharmacology. 2:1989;299-308.
23. Mansbach R.S., Geyer M.A. Parametric determinants in pre-stimulus modification of acoustic startle. Interaction with ketamine Psychopharmacology (Berlin). 105:1991;162-168.
24. Mansbach R.S., Geyer M.A., Braff D.L. Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology (Berlin). 94:1988;507-514.
25. Martinez Z.A., Ellison G.D., Geyer M.A., Swerdlow N.R. Effects of sustained cocaine exposure on sensorimotor gating of startle in rats. Psychopharmacology (Berlin). 142:1999;253-260.
26. Martinez Z.A., Ellison G.D., Geyer M.A., Swerdlow N.R. Effects of sustained phencyclidine exposure on sensorimotor gating of startle in rats. Neuropsychopharmacology. 21:1999;28-39.
27. Modvig K.M., Nielsen S.F. Psychological changes in children after anesthesia. A comparison between halothane and ketamine Acta Anaesth. Scand. 21:1977;541-544.
28. Olney J.W., Labruyere J., Price M.T. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science. 244:1989;1360-1362.
29. Olney J.W., Labruyere J., Wang G., Wozniak D.F., Price M.T., Sesma M.A. NMDA antagonist neurotoxicity. Mechanism and prevention Science. 254:1991;1515-1518.
30. Olney J.W., Farber N.B. Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiatry. 52:1995;998-1007.
31. Page P., Morgan M., Lok L. Ketamine anaesthesia in paediatric procedures. Acta Anaesth. Scand. 16:1972;155-160.
32. Perry W., Braff D. Information-processing deficits and thought disorder in schizophrenia. Am. J. Psychiatry. 151:1994;363-367.
33. Rigdon G. Differential effects of apomorphine on prepulse inhibition of acoustic startle reflex in two rat strains. Psychopharmacology (Berlin). 102:1990;419-421.
34. Stanwood G.D., McElligot S., Lu L., McGonigle P. Ontogeny of dopamine D3 receptors in the nucleus accumbens of the rat. Neurosci. Lett. 223:1997;13-16.
35. Sussman D.R. A comparative evaluation of ketamine anesthesia in children and adults. Anesthesiology. 40:1978;459-464.
36. Swerdlow N.R., Braff D.L., Geyer M.A., Koob G.F. Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics. Biol. Psychiatry. 21:1986;23-33.
37. Swerdlow N.R., Braff D.L., Masten V.L., Geyer M.A. Schizophrenia-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens. Psychopharmacology (Berlin). 101:1990;414-420.
38. Swerdlow N.R., Braff D.L., Taaid N., Geyer M.A. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch. Gen. Psychiatry. 51:1994;139-154.
39. Swerdlow N.R., Geyer M.A. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr. Bull. 24:1998;285-302.
40. Swerdlow N.R., Mansbach R.S., Geyer M.A., Pulvirenti L., Koob G.F., Braff D.L. Amphetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine. Psychopharmacology (Berlin). 100:1990;413-416.
41. Swerdlow N.R., Varty G.B., Geyer M.A. Discrepant findings of clozapine effects on prepulse inhibition of startle. Is it the route or the rat? Neuropsychopharmacology. 18:1998;50-56.
42. Van Eden C.G., Uylings H.B.M. Postnatal volumetric development of the prefrontal cortex in the rat. J. Comp. Neurol. 241:1985;253-267.
43. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry. 44:1987;660-669.
44. Weinberger D.R., Lipska B.K. Cortical maldevelopment, antipsychotic drugs, and schizophrenia. Search for common grounds Schizophr. Res. 16:1995;87-110.